Pathogen Reduced Cryoprecipitated Fibrinogen Complex Visit product website ; INTERCEPT® Blood System for Platelets and Plasma Visit US SiteVisit International Site ; At Cerus, we are proud of our consistent and unwavering focus to secure blood safety around the globe. See Mission and Values ; Annual Report Cerus’ Annual Meeting of Stockholders will be held online on Wednesday, June 7, 2023 Read More Latest Press Releases 06/05/2023 Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate READ MORE 05/04/2023 Cerus Corporation Announces First Quarter 2023 Financial Results READ MORE 04/20/2023 Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023 READ MORE 02/28/2023 Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results READ MORE view all press releases
